Back to Results
First PageMeta Content
Clinical research / Pharmaceutical industry / Pharmacology / Drug safety / Good manufacturing practice / Regulatory requirement / Clinical trial / Regulation of therapeutic goods / Natural Health Products Directorate / Pharmaceuticals policy / Pharmaceutical sciences / Health


Document Date: 2013-06-24 11:48:49

Open Document

File Size: 118,87 KB

Share Result on Facebook

City

Ottawa / /

Country

Canada / /

/

Facility

Publications Brooke Claxton Building / /

/

IndustryTerm

allergenic products / manufacturing activities / allergen products / drug product / health products / therapeutic product / allergenic product / manufacturing facilities / Treatment of Allergic Diseases / licensable activity involving allergenic products / non-subcutaneous allergenic products / unauthorized new products / drug products / to allergenic products / life-cycle management / Synthetic and recombinant allergenic products / food / Clinical trial applications / /

MedicalCondition

Allergic Diseases / allergy / immunological diseases / /

MedicalTreatment

immunotherapy / /

Organization

Health Products and Food Branch / Health Canada’s Biologics and Genetic Therapies Directorate / Natural Health Products Directorate / Genetic Therapies Directorate / Council for International Organizations of Medical Sciences Suspect Adverse Reaction Report / Biologics and Genetic Therapies Directorate / Research Ethics Board / office of Policy and International Collaboration Biologics / Marketed Health Products Directorate / /

/

Position

Investigator / Minister / Minister of Health / Minister of Public Works / /

ProgrammingLanguage

php / /

ProvinceOrState

Iowa / Ontario / /

Technology

GUI / /

URL

http /

SocialTag